The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT

Osteoporosis International

Volumn 25, Issue 3, 2014, Pages 1163-1172

  Ito, M ^a   Oishi, R ^b   Fukunaga, M ^c   Sone, T ^c   Sugimoto, T ^d   Shiraki, M ^e   Nishizawa, Y ^f   Nakamura, T ^g  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b ASAHI KASEI PHARMA CORPORATION   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^e RESEARCH INSTITUTE AND PRACTICE FOR INVOLUTIONAL DISEASES   (Japan)

^f Osaka Prefecture University   (Japan)

^g NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Once weekly injection; Osteoporosis; Proximal femur geometry; Quantitative computed tomography; Teriparatide

Indexed keywords

BONE DENSITY CONSERVATION AGENT; PARATHYROID HORMONE[1-34];

AGED; BIOMECHANICS; BONE DENSITY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECTS; FEMALE; FEMUR; FEMUR NECK; HUMAN; MULTICENTER STUDY; OSTEOPOROSIS, POSTMENOPAUSAL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMECHANICAL PHENOMENA; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMUR; FEMUR NECK; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; TERIPARATIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84894572659     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2596-y     Document Type: Article

References (19)

1. Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevenson RW, Zanelli JM (1983) Effects of two treatment regimens with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 112:1000-1006
2. Hock JM, Gera I (1992) Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 7:65-72
3. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441
4. Fujita T, Inoue T, Morii H, Morita R, Norimatsu H, Orimo H, Takahashi HE, Yamamoto K, Fukunaga M (1999) Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels. Osteoporos Int 9:296-306
5. Nakamura T, Sugimoto T, Nakano T, Kishimoto H, Ito M, Fukunaga M, Hagino H, Sone T, Yoshikawa H, Nishizawa Y, Fujita T, Shiraki M (2012) Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab 97:3097-3106
6. Ito M, Nakata T, Nishida A, Uetani M (2011) Age-related changes in bone density, geometry and biomechanical properties of the proximal femur: CT-based 3D hip structure analysis in normal postmenopausal women. Bone 48:627-630
7. Ito M, Wakao N, Hida T, Matsui Y, Abe Y, Aoyagi K, Uetani M, Harada A (2010) Analysis of hip geometry by clinical CT for the assessment of hip fracture risk in elderly Japanese women. Bone 46:453-457
8. Borggrefe J, Graeff C, Nickelsen TN, Marin F, Gluer CC (2010) Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: results from the EUROFORS study. JBMR 25:472-481
9. Uusi-Rasi K, Semanick LM, Zanchetta JR, Bogado CE, Eriksen EF, Sato M, Beck TJ (2005) Effects of teriparatide [rhPTH(1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 36:948-958
10. Ito M, Nakamura T, Fukunaga M, Shiraki M, Matsumoto T (2011) Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT. Bone 49:328-334
11. Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ, for the PaTH Study Investigators (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207-1215
12. Keaveny TM, Hoffmann PF, Singh M, Palermo L, Bilezikian JP, Greenspan SL, Black DM (2008) Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res 23:1974-1982
13. Macdonald HM, Nishiyama KK, Hanley DA, Boyd SK (2011) Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis. Osteoporos Int 22:357-362
14. Lindsay R, Zhou H, Cosman F, Nieves J, Dempster DW, Hodsman AB (2007) Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium. J Bone Miner Res 22:495-502
15. Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL (2003) Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18:539-543
16. Seeman E (2002) Pathogenesis of bone fragility in women and men. Lancet 359:1841-1850
17. Seeman E (2003) Periosteal bone formation-a neglected determinant of bone strength. N Engl J Med 349:320-323
18. Beck TJ, Oreskovic TL, Stone KL, Ruff CB, Ensrud K, Nevitt MC, Genant HK, Cummings SR (2001) Structural adaptation to changing skeletal load in the progression toward hip fragility: the study of osteoporotic fractures. J Bone Miner Res 16:1108-1119
19. Feik SA, Thomas CD, Bruns R, Clement JG (2000) Regional variations in cortical modeling in the femoral mid-shaft: sex and age differences. Am J Phys Anthropol 112:191-205